The Falsified Medicines Directive (FMD) 2011/62/EU introduced new requirements to enhance the security of the European supply chain. Where the MHRA has identified risks to the security of the supply chain, FMD Alerts are issued.

The MHRA are recalling certain batches of two medicines to a patient level - Neupro 4mg/24hr patches and Vimpat 100mg tablets.

For more information on this FMD alert see MHRA website at link below

https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency